Cargando…
1359. Clinical Experience and Challenges Utilizing Clofazimine in the Treatment of Nontuberculous Mycobacterial Pulmonary Infections
BACKGROUND: Nontuberculous mycobacterial (NTM) pulmonary infections are increasingly common and associated with significant morbidity and mortality. Treatment is challenging given high rates of antimicrobial resistance, the need for prolonged therapy with multiple agents, and poor medication tolerab...
Autores principales: | Mercurio, Amanda, Fredenrich, Jaela, Gompf, Sandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808959/ http://dx.doi.org/10.1093/ofid/ofz360.1223 |
Ejemplares similares
-
Clofazimine in Nontuberculous Mycobacterial Infections: A Growing Niche
por: McGuffin, Sarah A, et al.
Publicado: (2017) -
Clofazimine for Rapidly Growing Mycobacterial Infections
por: Carey, George B, et al.
Publicado: (2017) -
2392. Fosfomycin Utilization and Outcomes in a Large VA Medical Center Over a Decade
por: Kraitman, Natan, et al.
Publicado: (2018) -
1386. Reduction in Expected Survival Associated with Nontuberculous Mycobacterial Pulmonary Infection
por: Mourad, Ahmad, et al.
Publicado: (2019) -
Real-World Data Collection from Expanded Access Case Studies for the Treatment of Nontuberculous Mycobacterial Infection with Clofazimine
por: Gravelin, Misty, et al.
Publicado: (2023)